Skip to main content
OpenTrials

Clinical trial condition

Uterine Cervical Dysplasia

Explore clinical trials studying Uterine Cervical Dysplasia. Study availability and eligibility vary by location and protocol.

277 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Uterine Cervical Dysplasia trial results

Completed

A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women

NCT00000758

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +23 more
Locations
  • Usc La Nichd Crs Los Angeles, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Cook County Hosp. CORE Ctr. Chicago, Illinois, United States
View all 21 locations
View Trial Details
Completed

Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors

NCT00001073

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +28 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
View all 40 locations
View Trial Details
Completed

A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects

NCT03438006

Conditions
Cervical Intraepithelial Neoplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations
  • GSK Investigational Site Foshan, Guangdong, China
  • GSK Investigational Site Shenzhen, Guangdong, China
  • GSK Investigational Site Shenzhen, Guangdong, China
  • GSK Investigational Site Changzhou, Jiangsu, China
View Trial Details
Completed

Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)

NCT02354534

Conditions
Cervical Intraepithelial Neoplasia Grade 2/3, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Johns Hopkins Outpatient Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Greater Baltimore Medical Center Towson, Maryland, United States
View Trial Details

Related conditions